Grantham, Mayo, Van Otterloo & Co (GMO)’s CNB Financial Corp CCNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-9,559
Closed -$227K 710
2022
Q4
$227K Sell
9,559
-1,300
-12% -$32.2K ﹤0.01% 665
2022
Q3
$256K Sell
10,859
-7,408
-41% -$190K ﹤0.01% 649
2022
Q2
$442K Hold
18,267
﹤0.01% 625
2022
Q1
$481K Hold
18,267
﹤0.01% 603
2021
Q4
$484K Hold
18,267
﹤0.01% 603
2021
Q3
$445K Hold
18,267
﹤0.01% 606
2021
Q2
$417K Buy
18,267
+4,400
+32% +$107K ﹤0.01% 637
2021
Q1
$341K Buy
+13,867
New +$328K ﹤0.01% 763
2020
Q4
Sell
-16,300
Closed -$242K 812
2020
Q3
$242K Sell
16,300
-8,844
-35% -$145K ﹤0.01% 719
2020
Q2
$451K Sell
25,144
-700
-3% -$11.8K ﹤0.01% 637
2020
Q1
$488K Sell
25,844
-1,400
-5% -$37K ﹤0.01% 598
2019
Q4
$890K Hold
27,244
0.01% 538
2019
Q3
$782K Sell
27,244
-300
-1% -$8.25K 0.01% 579
2019
Q2
$778K Hold
27,544
0.01% 556
2019
Q1
$696K Buy
+27,544
New +$716K 0.01% 534

Other funds holding CCNE

Grantham, Mayo, Van Otterloo & Co (GMO)'s CCNE Position: Q1 2023 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of CNB Financial Corp (CCNE) in Q1 2023, closing a stake of 9,559 shares — an estimated $227K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in CCNE in Q1 2019 and held it in 15 quarters. The position peaked at $890K in Q4 2019. 101 funds tracked by Wall St. Rank hold CCNE as of Q1 2023.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining CNB Financial Corp position as of Q1 2023 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 9,559 CNB Financial Corp shares in Q1 2023, an estimated $227K.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in CNB Financial Corp in Q1 2019 and held it in 15 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s CNB Financial Corp position peaked at $890K in Q4 2019.
  • 101 funds tracked by Wall St. Rank held CNB Financial Corp as of Q1 2023.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2023, filed 12 May 2023.